Superior 12-month progression-free survival with frontline DVd versus VRd in patients with newly diagnosed multiple myeloma: a multicenter propensity score-matched analysis.
- DOI
- 10.1186/s12967-026-08637-6
- Published
- 2026 Aug 12
- Container
- Journal of translational medicine
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1186/s12967-026-08637-6,
title = {Superior 12-month progression-free survival with frontline DVd versus VRd in patients with newly diagnosed multiple myeloma: a multicenter propensity score-matched analysis.},
author = {Jiang H and Li Q and Wang L and Dou X and Leng Q and Miao M and Yang Y and Zhang M and Li Y and Li J and Zhang R and Lv Y and Liu Z and Wang H and Li Y and Li R and Zhang R and Tian F and Jiang Y and Wang J and Wang M and Wang X and He X and Lu J and Liao A},
year = {2026},
journal = {Journal of translational medicine},
doi = {10.1186/s12967-026-08637-6},
url = {https://doi.org/10.1186/s12967-026-08637-6}
}RIS
TY - JOUR TI - Superior 12-month progression-free survival with frontline DVd versus VRd in patients with newly diagnosed multiple myeloma: a multicenter propensity score-matched analysis. AU - Jiang H AU - Li Q AU - Wang L AU - Dou X AU - Leng Q AU - Miao M AU - Yang Y AU - Zhang M AU - Li Y AU - Li J AU - Zhang R AU - Lv Y AU - Liu Z AU - Wang H AU - Li Y AU - Li R AU - Zhang R AU - Tian F AU - Jiang Y AU - Wang J AU - Wang M AU - Wang X AU - He X AU - Lu J AU - Liao A PY - 2026 JO - Journal of translational medicine DO - 10.1186/s12967-026-08637-6 UR - https://doi.org/10.1186/s12967-026-08637-6 ER -
APA
H, J., Q, L., L, W., X, D., Q, L., M, M., Y, Y., M, Z., Y, L., J, L., R, Z., Y, L., Z, L., H, W., Y, L., R, L., R, Z., F, T., Y, J., J, W., M, W., X, W., X, H., J, L., & A, L. (2026). Superior 12-month progression-free survival with frontline DVd versus VRd in patients with newly diagnosed multiple myeloma: a multicenter propensity score-matched analysis.. Journal of translational medicine. https://doi.org/10.1186/s12967-026-08637-6
Source records
- pubmed · retrieved 2026-09-26T02:27:11.440Z